Han Yu-Ling, Cao Xian-E, Wang Ju-Xun, Dong Chun-Ling, Chen Hong-Tao
Department of Breast and Thyroid Surgery, Linyi People's Hospital, Linyi, 276000 People's Republic of China.
Department of Geriatrics, Linyi People's Hospital, North Park Road, 200 Meters East of Municipal Party School, Linyi, 276000 Shandong Province People's Republic of China.
Springerplus. 2016 Dec 22;5(1):2107. doi: 10.1186/s40064-016-3786-9. eCollection 2016.
This study intends to investigate the correlations of miR-124a and miR-30d with clinicopathological features of breast cancer (BC) patients with type 2 diabetes mellitus (T2DM). A total of 72 BC patients with T2DM (diabetic group) and 144 BC patients without T2DM (non-diabetic group) were enrolled in this study. Blood glucose was detected by glucose oxidase methods. Glycosylated hemoglobin (HbA1c) was measured by high performance liquid chromatography. Fasting insulin (FIns) was measured by chemiluminescent microparticle immunoassay. Automatic biochemical analyzer was used to detect triglyceride, total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C). Estradiol (E) was detected by radioimmunoassay. Homeostasis model assessment was applied to assess the insulin resistance (HOMA-IR) and β-cell insulin secretion (HOMA-IS). The expressions of miR124a and miR-30d were measured by quantitative real-time polymerase chain reaction (qRT-PCR). There were significant differences in age, the ratio of menopause, body mass index (BMI), HDL-C, TC, 2-h plasma glucose (2hPG), FIns, HbA1c, HOMA-IS and HOMA-IR between the diabetic and non-diabetic groups. The diabetic group had higher incidence of lymph node metastasis than non-diabetic group. The miR-124a expression was down-regulated while the miR-30d expression was up-regulated in BC patients with T2DM. The correlation analysis showed that miR-124a expression was positively correlated with HDL-C, while it was negatively correlated with age, HbA1c, LDL-C and E. However, the miR-30d expression was negatively correlated with HDL-C but positively correlated with age, HbA1c, LDL-C and E. In conclusion, miR-124a and miR-30d may be correlated with clinicopathological features of BC patients with T2DM. The miR-124a and miR-30d could serve as novel biomarkers for early diagnosis of BC in patients with T2DM.
本研究旨在探讨miR-124a和miR-30d与2型糖尿病(T2DM)乳腺癌(BC)患者临床病理特征的相关性。本研究共纳入72例T2DM的BC患者(糖尿病组)和144例无T2DM的BC患者(非糖尿病组)。采用葡萄糖氧化酶法检测血糖。采用高效液相色谱法测定糖化血红蛋白(HbA1c)。采用化学发光微粒子免疫分析法测定空腹胰岛素(FIns)。使用自动生化分析仪检测甘油三酯、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)和低密度脂蛋白胆固醇(LDL-C)。采用放射免疫分析法检测雌二醇(E)。应用稳态模型评估法评估胰岛素抵抗(HOMA-IR)和β细胞胰岛素分泌(HOMA-IS)。采用定量实时聚合酶链反应(qRT-PCR)检测miR124a和miR-30d的表达。糖尿病组和非糖尿病组在年龄、绝经比例、体重指数(BMI)、HDL-C、TC、餐后2小时血糖(2hPG)、FIns、HbA1c、HOMA-IS和HOMA-IR方面存在显著差异。糖尿病组淋巴结转移发生率高于非糖尿病组。T2DM的BC患者中miR-124a表达下调而miR-30d表达上调。相关性分析显示,miR-124a表达与HDL-C呈正相关,而与年龄、HbA1c、LDL-C和E呈负相关。然而,miR-30d表达与HDL-C呈负相关,但与年龄、HbA1c、LDL-C和E呈正相关。总之,miR-124a和miR-30d可能与T2DM的BC患者临床病理特征相关。miR-124a和miR-30d可作为T2DM患者BC早期诊断的新型生物标志物。